✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Tiapride is an investigational drug.
There have been 5 clinical trials for Tiapride. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2009.
The most common disease conditions in clinical trials are Disease, Psychotic Disorders, and Sialorrhea. The leading clinical trial sponsors are Tirat Carmel Mental Health Center, Beersheva Mental Health Center, and Assistance Publique - Hôpitaux de Paris.
Recent Clinical Trials for Tiapride
|Pharmacovigilance in Gerontopsychiatric Patients||Hannover Medical School||Phase 3|
|Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis||Instituto de Salud Carlos III||Phase 3|
|Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis||Fundación Pública Andaluza Progreso y Salud||Phase 3|